This inventor holds 1 USPTO granted patent and 6 published patent applications and 2 EPO patents. Top assignee: Spur Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Romuald Corbau: Innovator in Polynucleotide Technology
Introduction
Romuald Corbau is a notable inventor based in St Albans, GB. He has made significant contributions to the field of biotechnology, particularly in the area of polynucleotides. His work focuses on innovative solutions that have the potential to impact various medical applications.
Latest Patents
Romuald Corbau holds a patent for his invention related to polynucleotides. The patent describes polynucleotides comprising a GBA nucleotide sequence that encodes a GCase protein or a fragment thereof, wherein a portion of the coding sequence is not wild type. Additionally, the invention includes viral particles comprising a recombinant genome that incorporates the polynucleotide, as well as compositions and methods for their use.
Career Highlights
Corbau is associated with Spur Therapeutics Limited, where he applies his expertise in biotechnology to advance research and development. His innovative approach has led to the creation of valuable intellectual property that contributes to the company's mission.
Collaborations
Romuald Corbau collaborates with Jenny McIntosh, leveraging their combined expertise to drive forward their research initiatives. Their partnership exemplifies the importance of teamwork in the field of innovation.
Conclusion
Romuald Corbau's work in polynucleotide technology showcases his commitment to advancing biotechnology. His patent and collaborations highlight the potential for significant advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile